Blog

In the traditional pharmaceutical paradigm, the “finish line” of manufacturing is often followed by a weeks-long waiting period. This is the era of end-product testing,

In the competitive landscape of biologics production, the “upstream” phase—where living cells are engineered to express a target molecule—often captures the most attention. However, for